Meghraj Vivekanand Suryawanshi | Pharmaceutics | Innovative Research Award

Published-on by Indian Scientist

Innovative Research Award

Meghraj Vivekanand Suryawanshi
Affiliation Savitribai Phule Pune University
Country India
Scopus ID 58037948200
Documents 48
Citations 104
h-index 5
Subject Area Pharmaceutics
Event Indian Scientist Awards
ORCID 0000-0003-3958-2813

Meghraj Vivekanand Suryawanshi

Savitribai Phule Pune University, India

Meghraj Vivekanand Suryawanshi has contributed to the field of Pharmaceutics through research activities reflected in indexed publications, citations, and measurable scholarly impact. His academic profile demonstrates sustained engagement in pharmaceutical sciences and related research domains, supporting scientific knowledge dissemination and interdisciplinary collaboration.[1][2]

Abstract

This article presents an academic overview of Meghraj Vivekanand Suryawanshi and his scholarly contributions within the field of Pharmaceutics. The profile highlights publication activity, citation performance, research engagement, and academic impact indicators documented through internationally recognized indexing platforms. The assessment considers research productivity, contribution to pharmaceutical sciences, and relevance to innovation-oriented scientific recognition programs.[1]

Keywords

Pharmaceutics, Drug Delivery Systems, Pharmaceutical Research, Scientific Innovation, Research Impact, Scholarly Publications, Citation Analysis, Academic Recognition, Pharmaceutical Sciences, Innovative Research Award.

Introduction

Research in pharmaceutics plays a fundamental role in improving therapeutic outcomes, formulation technologies, drug delivery mechanisms, and pharmaceutical manufacturing processes. Academic researchers contribute to the advancement of healthcare through experimental investigations, translational research, and dissemination of scientific findings. Meghraj Vivekanand Suryawanshi’s scholarly profile reflects active participation in these efforts through publication and citation records indexed in major academic databases.[1]

Research Profile

Meghraj Vivekanand Suryawanshi is affiliated with Savitribai Phule Pune University, a recognized institution engaged in higher education and scientific research. His documented scholarly profile includes research publications indexed in Scopus, demonstrating contributions to pharmaceutical sciences and related disciplines.[1]

  • Institutional Affiliation: Savitribai Phule Pune University.
  • Country of Research Activity: India.
  • Scopus Indexed Documents: 48.
  • Citation Count: 104.
  • h-index: 5.
  • Primary Subject Area: Pharmaceutics.

Research Contributions

The research contributions associated with this profile encompass pharmaceutical formulation studies, drug delivery approaches, evaluation methodologies, and related pharmaceutical investigations. Such work supports the broader objective of improving therapeutic effectiveness and scientific understanding within the pharmaceutical sector.[3]

  • Development and evaluation of pharmaceutical formulations.
  • Investigation of drug delivery technologies.
  • Research supporting pharmaceutical quality and efficacy assessment.
  • Contribution to peer-reviewed scientific literature.
  • Participation in collaborative and interdisciplinary research activities.

Publications

Publication activity serves as an important indicator of academic productivity. The available bibliometric profile demonstrates a record of peer-reviewed outputs that contribute to knowledge generation in pharmaceutical sciences and allied research areas.[1]

  1. Research articles indexed in international scientific databases.
  2. Studies related to pharmaceutical formulation and evaluation.
  3. Scientific communications supporting evidence-based pharmaceutical development.
  4. Collaborative publications contributing to interdisciplinary knowledge exchange.

Research Impact

Research impact may be evaluated through bibliometric indicators including publication volume, citation performance, and h-index metrics. With 48 indexed documents, 104 citations, and an h-index of 5, the profile demonstrates measurable scholarly visibility within the academic community.[1]

  • Evidence of sustained scholarly publication activity.
  • Research findings referenced by other investigators.
  • Contribution to scientific discourse within pharmaceutics.
  • Academic visibility reflected through citation metrics.

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities contribute to scientific advancement and innovation. Based on the documented research profile, publication record, citation indicators, and engagement in pharmaceutical sciences, Meghraj Vivekanand Suryawanshi demonstrates attributes commonly associated with academic recognition programs emphasizing innovation, research productivity, and knowledge dissemination.[1][2]

Conclusion

Meghraj Vivekanand Suryawanshi’s academic profile reflects sustained participation in pharmaceutical research and scholarly publication. Through documented contributions in Pharmaceutics, indexed publications, citation performance, and measurable research indicators, the profile represents ongoing engagement with scientific inquiry and evidence-based knowledge development. These characteristics align with the objectives of professional research recognition initiatives such as the Innovative Research Award.[1]

References

  1. Scopus author details: Meghraj Vivekanand Suryawanshi, Author ID 58037948200. Scopus.https://www.scopus.com/authid/detail.uri?authorId=58037948200
  2. Medicinal and Nutritional Importance of Hypericum perforatum in Human Health.https://link.springer.com/chapter/10.1007/978-981-95-3620-7_13
  3. Neuroprotective efficacy of Nyctanthes arbor-tristis in a rotenone-induced rat model of Parkinson’s disease

    https://www.sciencedirect.com/science/article/abs/pii/S0378874126006781?via%3Dihub

Jon Jyoti Sahariah | Medicinal Chemistry | Research Excellence Award

Published-on by Indian Scientist

Research Excellence Award

Jon Jyoti Sahariah
Dibrugarh University, India

Jon Jyoti Sahariah
Affiliation Dibrugarh University
Country India
Scopus ID 57225212218
Documents 19
Citations 125
h-index 6
Subject Area Medicinal Chemistry
Event Indian Scientist Awards

Jon Jyoti Sahariah is an academic researcher affiliated with Dibrugarh University, India, whose scholarly activities are associated with medicinal chemistry, pharmaceutical sciences, drug delivery systems, and therapeutic development. His published research contributions demonstrate engagement with contemporary challenges in drug discovery, targeted therapeutics, and biomedical innovation. Through peer-reviewed publications, citation impact, and interdisciplinary collaborations, he has contributed to advancing scientific understanding within medicinal chemistry and related biomedical disciplines.[1]

Abstract

This article presents an academic overview of Jon Jyoti Sahariah and his scholarly contributions within medicinal chemistry and pharmaceutical research. The profile summarizes research interests, publication records, citation metrics, scientific influence, and relevance to recognition through the Research Excellence Award. The assessment is based on publicly available scholarly indicators and peer-reviewed academic outputs.[1]

Keywords

Medicinal Chemistry, Drug Discovery, Pharmaceutical Sciences, Targeted Drug Delivery, Cancer Therapeutics, Liposomal Formulations, Biomedical Research, Therapeutic Development, Scientific Publications, Research Excellence.

Introduction

Medicinal chemistry plays a critical role in the development of novel therapeutic agents and advanced healthcare solutions. Researchers working in this field contribute to the identification, optimization, and evaluation of biologically active compounds for the prevention and treatment of diseases. Jon Jyoti Sahariah’s academic activities align with these objectives through investigations focused on pharmaceutical formulations, drug delivery systems, and therapeutic innovations. His work reflects interdisciplinary collaboration across chemistry, pharmacy, and biomedical sciences.[2]

Research Profile

The scholarly profile of Jon Jyoti Sahariah demonstrates sustained participation in scientific research and publication. According to available bibliometric indicators, his research output includes nineteen indexed documents, 125 citations, and an h-index of six. These metrics indicate measurable academic visibility and engagement within the scientific community. His publications encompass medicinal chemistry, drug delivery technologies, cancer therapeutics, and pharmaceutical innovations.[1]

  • Affiliation with Dibrugarh University, India.
  • Research specialization in medicinal chemistry and pharmaceutical sciences.
  • Indexed publications in peer-reviewed journals.
  • Interdisciplinary collaboration involving drug discovery and therapeutic development.

Research Contributions

Jon Jyoti Sahariah has contributed to studies involving natural bioactive compounds, targeted cancer therapies, liposomal drug delivery systems, and pharmaceutical technologies. Several publications examine mechanisms for improving therapeutic efficacy while reducing adverse effects associated with conventional treatments. Research efforts in these domains contribute to ongoing developments in precision medicine and translational pharmaceutical science.[3]

  • Investigation of natural compounds with therapeutic potential.
  • Research on advanced liposomal drug delivery systems.
  • Contributions to targeted cancer therapy methodologies.
  • Participation in multidisciplinary biomedical research projects.

Publications

Selected scholarly works associated with Jon Jyoti Sahariah include publications addressing cancer chemotherapy, liposomal drug delivery, and medicinal chemistry innovations. Representative studies include highly cited articles focusing on natural bioactive compounds and targeted therapeutic approaches.[3]

  1. Cancer Chemotherapy via Natural Bioactive Compounds.
  2. Advancing Liposomal Doxorubicin for Targeted Cancer Therapy.
  3. Research involving pharmaceutical formulation and drug delivery technologies.
  4. Studies related to medicinal chemistry and therapeutic development.

Research Impact

Research impact can be assessed through publication output, citation frequency, collaborative scholarship, and relevance to scientific advancement. The citation record associated with Jon Jyoti Sahariah indicates that his work has been referenced by researchers in related fields, reflecting scholarly engagement and knowledge dissemination. Contributions to pharmaceutical sciences and medicinal chemistry support ongoing scientific dialogue regarding improved therapeutic interventions.[1]

Award Suitability

The Research Excellence Award recognizes researchers demonstrating meaningful scholarly contributions, scientific productivity, and academic influence. Based on available publication records, citation metrics, and participation in medicinal chemistry research, Jon Jyoti Sahariah exhibits characteristics consistent with the objectives of academic recognition programs. His work contributes to knowledge advancement in pharmaceutical and biomedical sciences while supporting innovation in therapeutic research.[1][4]

Conclusion

Jon Jyoti Sahariah has established a scholarly profile characterized by contributions to medicinal chemistry, drug delivery systems, and pharmaceutical sciences. Through peer-reviewed publications, citation impact, and collaborative scientific efforts, he has participated in research addressing significant healthcare and therapeutic challenges. His academic record supports consideration for professional recognition through the Research Excellence Award and reflects ongoing engagement with scientific advancement.[1]

References

  1. Scopus author details: Jon Jyoti Sahariah, Author ID 57225212218. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57225212218
  2. Cancer chemotherapy via natural bioactive compounds. https://www.benthamdirect.com/content/journals/cddt/10.2174/1570163819666220331095744
  3. From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy. https://www.sciencedirect.com/science/article/pii/S2666845925000601
  4. Revolutionizing patient care: 3D printing for customized medical devices and therapeutics. https://link.springer.com/article/10.1007/s44174-025-00324-2

Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

Published-on by Indian Scientist

Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

IFTM University, Moradabad, India

Akash Vikal is an emerging pharmaceutical researcher specializing in pharmaceutics, nanomedicine, advanced drug delivery systems, and cancer therapeutics. His academic and research contributions primarily focus on the development of innovative formulation strategies designed to improve therapeutic efficacy, targeted delivery, and patient outcomes. Through extensive research in liposomal formulations, nanocarriers, gene delivery systems, and ocular therapeutics, he has established himself as a promising young contributor to modern pharmaceutical sciences.His research portfolio reflects interdisciplinary expertise integrating pharmaceutical technology, nanotechnology, oncology, ophthalmic therapeutics, and translational medicine. With numerous peer-reviewed publications, book chapters, and scientific presentations, he has actively contributed to advancing pharmaceutical innovation and drug delivery research.

Professional Profile 

Education

Akash Vikal completed a Bachelor of Pharmacy (B.Pharm.) from Shri Gopichand College of Pharmacy with strong academic performance. He further pursued a Master of Pharmacy (M.Pharm.) in Pharmaceutics from ISF College of Pharmacy, where he specialized in advanced pharmaceutical formulation and drug delivery systems. His postgraduate research focused on the “Development and Characterization of Ferulic Acid and Docetaxel Loaded Liposomes Against Breast Cancer” under the guidance of Balak Das Kurmi.

Professional Experience

During his academic journey, Akash Vikal gained industrial exposure through internship training at HIS Pharmaceuticals Pvt. Ltd., where he developed practical knowledge related to pharmaceutical manufacturing and formulation processes. He has also actively contributed to scientific communication and peer-review activities, including reviewing submissions for reputed journals such as Dovepress journals Clinical Ophthalmology and Eye and Brain. In addition, he delivered an academic webinar on scientific writing and publication strategies for researchers and healthcare professionals.

Research Interest

He has contributed extensively to pharmaceutical and biomedical research through numerous publications in reputed international journals. His research covers areas such as metal-organic frameworks in drug delivery, PROTAC-based cancer therapy, nanoparticle-mediated antimicrobial strategies, CRISPR-assisted nanotechnology, nanocarrier systems for ocular therapeutics, and phytoconstituent-based anticancer therapies. Several of his works have been published in recognized journals including Applied Materials Today, Drug Delivery and Translational Research, AAPS PharmSciTech, Current Pharmaceutical Design, and Experimental Eye Research.

Award and Honor

Akash Vikal has received recognition for his academic and scientific contributions through participation in national and international conferences, workshops, and faculty development programs. He earned a Certificate of Excellence in Peer Reviewing for his contribution to academic quality enhancement. His involvement in intellectual property awareness programs, pharmaceutical research conferences, and specialized training workshops reflects his commitment to continuous professional development and scientific advancement.

Conclusion

Mebratu Tafesse Teferi demonstrates strong potential for the Best Researcher Award. His substantial academic qualifications, leadership experience, and dedication to educational research are commendable. His publications reflect significant contributions to Ethiopian education and leadership studies, making him a valuable candidate for the award. To further enhance his candidacy, Mebratu could focus on broadening his research scope, fostering international collaborations, and increasing his publication reach in globally recognized journals.

Publications Top Noted

  • Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies
    Authors: Akash Vikal, Rashmi Maurya, Pradeep Kumar, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • Liposomal Paclitaxel in Breast Cancer Therapy: Advances, Clinical Insights, and Future Perspectives
    Authors: Akash Vikal, Rashmi Maurya, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • A Mini-Review on Unlocking Cognitive Enhancement: An Innovative Strategy for Optimal Brain Functions
    Authors: Akash Vikal, Rashmi Maurya, Brij Bihari Patel, Preeti Patel, Manish Kumar, Balak Das Kurmi
    Year: 2025
  • Andrographis paniculata in Fatty Liver Disease: Mechanisms, Nanocarrier Approaches, and Therapeutic Potential
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Development of Mucopenetrating Pegylated Liposomes Functionalized with Sodium Taurocholate for Enhanced Oral Insulin Delivery
    Authors: Akash Vikal, Rashmi Maurya, Balak Das Kurmi, S. Jindal, R. K. Narang
    Year: 2025
  • From Resistance to Response: Metallic Nanoparticles as Game Changers in Triple Negative Breast Cancer Therapy
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, R. K. Narang, Balak Das Kurmi
    Year: 2025
  • Lutein as a Liver Guardian: Insights into its Hepatoprotective Mechanisms, Bioavailability, and Emerging Therapeutic Roles
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Nanoemulsion Technology in Oral Drug Delivery: A Path to Enhanced Solubility and Bioavailability
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Role of dePEGylation in Vesicular Carriers-Mediated Stimuli-Responsive Drug Delivery to Tumors
    Authors: Akash Vikal, Rashmi Maurya, Abhinav Vashishat, Taqdir Singh, Satyam Khare, Preeti Patel, Balak Das Kurmi
    Year: 2025

 

Vidhya Bhusari | Pharmaceutical Sciences | Women Researcher Award

Published-on by Indian Scientist

Dr. Vidhya Bhusari | Pharmaceutical Sciences | Women Researcher Award

Chitkara College of Pharmacy, Chitkara University, India

Dr. Vidhya Kishore Bhusari is an accomplished pharmaceutical chemist with advanced training in pharmaceutical chemistry and extensive experience spanning academia and the pharmaceutical industry. She has contributed significantly to analytical method development, drug regulatory affairs, and quality assurance. Her research focuses on green analytical chemistry, HPTLC, HPLC, LC-MS techniques, stability-indicating methods, and QbD approaches. She is a recognized award recipient with impactful publications, patents, and scholarly books, contributing meaningfully to pharmaceutical education and research advancement.

Research Metrics (Scopus)

200
150
100
50
10
5
0

Citations
198

Documents
40

h-index
9

Citations

Documents

h-index

Featured Publications

Hardik Kumar | Pharmaceutical Sciences | Best Researcher Award

Published-on by Indian Scientist

Mr. Hardik Kumar | Pharmaceutical Sciences | Best Researcher Award

CT University,  India

Hardik Kumar is a pharmaceutical sciences academic and researcher specializing in pharmacy practice and clinical research. He holds advanced training up to doctoral coursework level, with postgraduate qualifications in pharmacy practice. His experience includes teaching, clinical exposure, pharmacovigilance activities, and academic coordination. His research interests span epilepsy, cardiometabolic disorders, infectious diseases, pharmacotherapy, drug safety, and quality-of-life assessment. He has authored multiple peer-reviewed publications, books, patents, and copyrights, received national-level awards, and actively contributes as a reviewer, speaker, and member of professional scientific bodies.

Citation Metrics (Scopus)

25
20
15
10
5
0

Citations
24

Documents
9

h-index
3

Citations

Documents

h-index

Featured Publications

Pooja Mathur | Pharmaceutics | Excellence in Research Award

Published-on by Indian Scientist

Pooja Mathur | Pharmaceutics | Excellence in Research Award

GD Goenka University | India

Dr. Pooja Mathur is an accomplished academic and researcher in Pharmaceutics with advanced doctoral training and extensive experience in teaching, research, and academic coordination. She has contributed significantly to pharmaceutical sciences through high-impact publications, books, patents, and interdisciplinary research. Her research interests include nanoformulations, drug delivery systems, phytopharmaceuticals, oncology therapeutics, and translational nanomedicine. She actively serves as a reviewer for reputed international journals and has received multiple recognitions for academic excellence, research output, and institutional contributions, reflecting her strong commitment to innovation and scholarly leadership.

Citation Metrics (Scopus)

150
20
10
5
0

Citations
149

Documents
22

h-index
4

Citations

Documents

h-index

Featured Publications

Pooja Rani | Pharmaceutical sciences | Best Researcher Award

Published-on by Indian Scientist

Dr. Pooja Rani | Pharmaceutical sciences | Best Researcher Award

CGC University | India

Dr. Pooja Rani is an accomplished pharmaceutical scientist and academician currently serving as an Assistant Professor, with expertise spanning pharmaceutics, drug delivery systems, and translational pharmaceutical research. She holds a doctoral degree in Pharmaceutical Sciences along with postgraduate and undergraduate training in Pharmacy, building a strong foundation in formulation development and therapeutic design. Her teaching and administrative experience across reputed institutions includes curriculum delivery, research mentoring, academic coordination, and student development initiatives. Dr. Rani’s research interests focus on natural polymer–based nanofibers, gastroretentive drug delivery systems, microneedles, microsponge technology, and quality-by-design approaches for advanced formulations. She has authored numerous research and review articles in high-impact, peer-reviewed journals, contributed to books, and holds a granted patent in biomedical diagnostics. Her scholarly contributions have been recognized with a Best Researcher Award for outstanding publication impact. Through her integrated role as educator, researcher, and innovator, Dr. Rani continues to advance pharmaceutical science with a commitment to patient-centric and sustainable drug development.

Citation Metrics (Scopus)

15
10
5
0

Citations
12

Documents
2

h-index
2

Citations

Documents

h-index



View Scopus Author Profile

Featured Publications

In Silico Screening of Phytoconstituents and Medicinal Plants as Antidiabetic Drug Discovery

– Corrosion Management (ISSN: 1355-5243), 34(2), 227–245 · 1 Citation · 2024

From nature to nurture: A review on the escalating role of locust bean gum in food, pharma, and cosmeceuticals

– International Journal of Biological Macromolecules, Article 149376 · 2025

Stem Cells to Organoids: Pioneering the Future of Regenerative Therapies

– Stem Cell Reviews and Reports, 1–26 · 2025

Yogeeta Agrawal | Pharmaceutical Sciences | Best Researcher Award

Published-on by Indian Scientist

Prof. Dr. Yogeeta Agrawal | Pharmaceutical Sciences | Best Researcher Award

SVKM NMIMS Global University | India

Dr. Yogeeta Agrawal Goyal is a Professor of Pharmaceutics at SVKM NMIMS Global University, Dhule, with more than 19 years of teaching and research experience. She holds a Ph.D. from Jaipur National University with research at AIIMS New Delhi, an M.Pharm with distinction and gold medal from The M.S. University of Baroda, a B.Pharm with multiple university gold medals from Nagpur University, and a PG Diploma in Patent Law from NALSAR University. Her research expertise lies in lipid-based nanoparticles, transdermal and controlled drug delivery, nose-to-brain targeting, and nanomedicine for brain and tumour therapies. She has published over 50 international and 3 national papers in reputed SCI-indexed journals with an impact factor above 183, authored two books, contributed several book chapters, and holds patents. She has guided numerous postgraduate and doctoral students, completed government and institutional funded projects from DBT, AYUSH, and SVKM, and presented at national and international forums. Her achievements include multiple gold medals, the G.P. Nair Award from IDMA, outstanding performance awards, and recognition through fellowships and grants. She is actively involved in academic associations such as IPA, APTI, and MSU Alumni, while also serving on editorial boards and advisory roles, making impactful contributions to pharmaceutical sciences through teaching, research, innovation, and community development.

Profiles: Scopus | Google Scholar | Orcid

Featured Publication

Goyal, S. N., Reddy, N. M., Patil, K. R., Nakhate, K. T., Ojha, S., Patil, C. R., … Agrawal, Y. O. (2016). Challenges and issues with streptozotocin-induced diabetes–A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chemico-Biological Interactions, 244, 49–63.

Agrawal, Y., Petkar, K. C., & Sawant, K. K. (2010). Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. International Journal of Pharmaceutics, 401(1–2), 93–102.

Agrawal, Y. O., Sharma, P. K., Shrivastava, B., Ojha, S., Upadhya, H. M., Arya, D. S., … Goyal, S. N. (2014). Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic heart disease model in diabetic rats. PLOS ONE, 9(11), e111212.

Goyal, S. N., Sharma, C., Mahajan, U. B., Patil, C. R., Agrawal, Y. O., Kumari, S., … Ojha, S. (2015). Protective effects of cardamom in isoproterenol-induced myocardial infarction in rats. International Journal of Molecular Sciences, 16(11), 27457–27469.

Eddin, L. B., Jha, N. K., Goyal, S. N., Agrawal, Y. O., Subramanya, S. B., Bastaki, S. M. A., … Ojha, S. (2022). Health benefits, pharmacological effects, molecular mechanisms, and therapeutic potential of α-bisabolol. Nutrients, 14(7), 1370.